SIRO Clinpharm Forms Alliance With VCRO, a Taiwan- based CRO

Pact enables SIRO's clients access to blooming Taiwan clinical research market

MUMBAI, India, April 21, 2010 – SIRO Clinpharm a Contract Research Organization (CRO) with a presence in
India, Western and Central Eastern Europe and the USA today announced its
alliance with Virginia Contract Research Organization Co., Ltd. (VCRO), a
Taiwan-based CRO.
VCRO has more [...]

MarketsandMarkets: Global Ophthalmology Devices Market 2009-2014 Worth US$16.2 Billion by 2014

DALLAS, Texas, April 21, 2010 – According to a new market research report, 'Global Ophthalmology Devices
Market (2009 – 2014), published by MarketsandMarkets (
www.marketsandmarkets.com), the total global ophthalmology devices
market is expected to be worth US$16.2 billion by 2014, and the U.S. market
will account for nearly 37.2% of the total revenues. The global IOL market
is expected [...]

Consider the ‘Whole-Man’ When Treating Prostate Cancer

Too Little Time Spent Discussing Emotional and Sexual Impact, Says New Survey

BARCELONA, April 21, 2010 – Health care professionals need to consider the impact of
prostate cancer on the 'whole man' rather than focusing on cancer treatment
in isolation, according to results from an international survey of prostate
cancer patients and their partners.
To [...]

Abbott Completes Acquisition of Facet Biotech

ABBOTT PARK, Illinois, April 21, 2010 – Abbott (NYSE: ABT) has completed its acquisition of Facet Biotech
Corporation, strengthening its pharmaceutical pipeline in immunology and
oncology.

The acquisition provides Abbott with a promising biologic intended to
treat multiple sclerosis (MS) and compounds that complement its existing
diverse oncology program. The new Abbott compounds include daclizumab [...]